Lorati Co., Ltd. has unveiled a groundbreaking natural therapy, Lorati Nano-Emulsion, designed to support full recovery for patients suffering from hemorrhagic and ischemic strokes. This innovative treatment stands out for its non-invasive approach, allowing patients to undergo therapy at home by consuming 1,600 to 2,000 cc daily, with recovery periods ranging from 12 to 30 months based on individual health conditions.
The therapy works by addressing the root causes of stroke damage, including the clearance of blood clots and foam cells, restoration of blood vessel elasticity, and the elimination of inhibitory molecules such as AGEs, ALEs, and excessive heavy metals. This process activates the body's endogenous stem cells to regenerate damaged brain tissue, offering a novel approach to stroke recovery that diverges from traditional stem cell transplants.
A notable success story involves a patient with a central pontine hemorrhagic stroke, one of the most severe types, who achieved a full recovery after 30 months of nano-emulsion therapy. This outcome has garnered attention from medical experts, including professors at National Taiwan University, and represents a historic milestone in stroke treatment.
Mr. David Lo, CEO of Lorati, emphasizes the therapy's potential to cure various forms of stroke, highlighting its significance in the medical field. For more information, visit https://www.lorati.com.tw.
